Los Angeles Capital Management
ORKA

Los Angeles Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Los Angeles Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.3K Sell
719
-583
-45% -$20.3K ﹤0.01% 1576
2025
Q4 		$36.6K Buy
+1,302
New +$36.3K ﹤0.01% 1688

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Los Angeles Capital Management's ORKA Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Oruka Therapeutics (ORKA) stake by 45% in Q1 2026, selling an estimated $20.3K and leaving 719 shares worth $35.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Los Angeles Capital Management first reported a position in ORKA in Q4 2025 and has held it in 2 quarters since. The position peaked at $36.6K in Q4 2025. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Los Angeles Capital Management held 719 shares of Oruka Therapeutics worth $35.3K as of Q1 2026.
  • Los Angeles Capital Management sold 583 Oruka Therapeutics shares in Q1 2026, an estimated $20.3K.
  • Oruka Therapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1576 holding.
  • Los Angeles Capital Management first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Los Angeles Capital Management's Oruka Therapeutics position peaked at $36.6K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.